跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,079 条关于
“BPL-300”
全部
10,079
临床试验
5,587
药物
2,508
机构
29
资讯
1,955
去年
Tourmaline Bio's Heart Disease Antibody Shows Promise in Phase 2, But Shares Fall Amid Competition Concerns
6个月前
AtaiBeckley Advances BPL-003 to Phase 3 Trials for Treatment-Resistant Depression Following FDA Approval
11个月前
FDA Grants Breakthrough Therapy Designation to BPL-003 Nasal Spray for Treatment-Resistant Depression
去年
Atai Life Sciences Reports Mixed Phase 2b Results as BPL-003 Succeeds While Inidascamine Falls Short
6天前
Lilly Closes $2.8B AtaiBeckley Acquisition, Adding Rapid-Acting Neuroplastogen BPL-003 for Treatment-Resistant Depression
去年
atai Life Sciences and Beckley Psytech Announce $390 Million Merger to Create Psychedelic Mental Health Leader
去年
TYRA-300: Novel FGFR3-Selective Inhibitor Shows Promise in Urothelial Cancer and Achondroplasia
去年
5-MeO-DMT Nasal Spray Shows Promise in Phase 2a Alcohol Use Disorder Trial
去年
HHS and NIH Launch "Generation Gold Standard" Universal Vaccine Platform to Combat Pandemic Threats
去年
TYRA-300 Shows Promise in FGFR3-Altered Urothelial Carcinoma
第 1 页,共 196 页
上一页
下一页